Genetic control of susceptibility to infection with Plasmodium chabaudi chabaudi AS in inbred mouse strains

Genes and Immunity

Volumn 13, Issue 2, 2012, Pages 155-163

  Laroque, A ^a   Min Oo, G ^a   Tam, M ^b   Radovanovic, I ^a   Stevenson, M M ^b   Gros, P ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

haplotype mapping; inbred mouse strains; malaria; Plasmodium chabaudi; QTL

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 9; ENZYME DEFICIENCY; FEMALE; GENETIC ANALYSIS; GENETIC REGULATION; GENETIC VARIABILITY; HAPLOTYPE; INFECTION CONTROL; MALARIA; MALE; MOUSE; NONHUMAN; PARASITEMIA; PHENOTYPE; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI CHABAUDI; PLASMODIUM CHABAUDI INFECTION; PRIORITY JOURNAL; PYRUVATE KINASE DEFICIENCY; STRAIN DIFFERENCE; SURVIVAL RATE; X CHROMOSOME;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; MALARIA; MALE; MICE; MICE, INBRED STRAINS; PHENOTYPE; PLASMODIUM CHABAUDI;

ANIMALIA; MUS; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI CHABAUDI;

EID: 84857789140     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.67     Document Type: Article

References (44)

1. Greenwood BM, Fidock DA, Kyle DE, Kappe SH, Alonso PL, Collins FH et al. Malaria: progress, perils, and prospects for eradication. J Clin Invest 2008; 118: 1266-1276.
2. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J et al. Artemisinin resistance in plasmodium falciparum malaria. N Engl J Med 2009; 361: 455-467.
3. Corbel V, N'Guessan R, Brengues C, Chandre F, Djogbenou L, Martin T et al. Multiple insecticide resistance mechanisms in Anopheles gambiae and Culex quinquefasciatus from Benin, West Africa. Acta Trop 2007; 101: 207-216.
4. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005; 77: 171-192.
5. Bongfen SE, Laroque A, Berghout J, Gros P. Genetic and genomic analyses of host-pathogen interactions in malaria. Trends Parasitol 2009; 25: 417-422.
6. Weatherall DJ. Genetic variation and susceptibility to infection: the red cell and malaria. Br J Haematol 2008; 141: 276-286.
7. Allison AC. Genetic control of resistance to human malaria. Curr Opin Immunol 2009; 21: 499-505.
8. Rihet P, Traore Y, Abel L, Aucan C, Traore-Leroux T, Fumoux F. Malaria in humans: plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am J Hum Genet 1998; 63: 498-505.
9. Timmann C, Evans JA, Konig IR, Kleensang A, Ruschendorf F, Lenzen J et al. Genome-wide linkage analysis of malaria infection intensity and mild disease. PLoS Genet 2007; 3: e48.
10. Flori L, Kumulungui B, Aucan C, Esnault C, Traore AS, Fumoux F et al. Linkage and association between plasmodium falciparum blood infection levels and chromosome 5q31-q33. Genes Immun 2003; 4: 265-268.
11. Garcia A, Marquet S, Bucheton B, Hillaire D, Cot M, Fievet N et al. Linkage analysis of blood plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am J Trop Med Hyg 1998; 58: 705-709.
12. Sakuntabhai A, Ndiaye R, Casademont I, Peerapittayamongkol C, Rogier C, Tortevoye P et al. Genetic determination and linkage mapping of plasmodium falciparum malaria related traits in Senegal. PLoS One 2008; 3: e2000.
13. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, Clark TG et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet 2009; 41: 657-665.
14. Lamb TJ, Brown DE, Potocnik AJ, Langhorne J. Insights into the immunopathogenesis of malaria using mouse models. Expert Rev Mol Med 2006; 8: 1-22.
15. Coltel N, Combes V, Hunt NH, Grau GE. Cerebral malaria-a neurovascular pathology with many riddles still to be solved. Curr Neurovasc Res 2004; 1: 91-110.
16. Li C, Seixas E, Langhorne J. Rodent malarias: the mouse as a model for understanding immune responses and pathology induced by the erythrocytic stages of the parasite. Med Microbiol Immunol 2001; 189: 115-126.
17. Stevenson MM, Riley EM. Innate immunity to malaria. Nat Rev Immunol 2004; 4: 169-180.
18. Fortin A, Stevenson MM, Gros P. Complex genetic control of susceptibility to malaria in mice. Genes Immun 2002; 3: 177-186.
19. Urban BC, Ing R, Stevenson MM. Early interactions between blood-stage plasmodium parasites and the immune system. Curr Top Microbiol Immunol 2005; 297: 25-70.
20. Fortin A, Stevenson MM, Gros P. Susceptibility to malaria as a complex trait: big pressure from a tiny creature. Hum Mol Genet 2002; 11: 2469-2478.
21. Fortin A, Belouchi A, Tam MF, Cardon L, Skamene E, Stevenson MM et al. Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8. Nat Genet 1997; 17: 382-383.
22. Foote SJ, Burt RA, Baldwin TM, Presente A, Roberts AW, Laural YL et al. Mouse loci for malaria-induced mortality and the control of parasitaemia. Nat Genet 1997; 17: 380-381.
23. Lin E, Pappenfuss T, Tan RB, Senyschyn D, Bahlo M, Speed TP et al. Mapping of the plasmodium chabaudi resistance locus char2. Infect Immun 2006; 74: 5814-5819.
24. Burt RA, Baldwin TM, Marshall VM, Foote SJ. Temporal expression of an H2-linked locus in host response to mouse malaria. Immunogenetics 1999; 50: 278-285.
25. Hernandez-Valladares M, Naessens J, Gibson JP, Musoke AJ, Nagda S, Rihet P et al. Confirmation and dissection of QTL controlling resistance to malaria in mice. Mamm Genome 2004; 15: 390-398.
26. Hernandez-Valladares M, Rihet P, ole-MoiYoi OK, Iraqi FA. Mapping of a new quantitative trait locus for resistance to malaria in mice by a comparative mapping approach with human chromosome 5q31-q33. Immunogenetics 2004; 56: 115-117.
27. Fortin A, Diez E, Rochefort D, Laroche L, Malo D, Rouleau GA et al. Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics 2001; 74: 21-35.
28. Fortin A, Cardon LR, Tam M, Skamene E, Stevenson MM, Gros P. Identification of a new malaria susceptibility locus (Char4) in recombinant congenic strains of mice. Proc Natl Acad Sci USA 2001; 98: 10793-10798.
29. Min-Oo G, Fortin A, Tam MF, Nantel A, Stevenson MM, Gros P. Pyruvate kinase deficiency in mice protects against malaria. Nat Genet 2003; 35: 357-362.
30. Min-Oo G, Tam M, Stevenson MM, Gros P. Pyruvate kinase deficiency: correlation between enzyme activity, extent of hemolytic anemia and protection against malaria in independent mouse mutants. Blood Cells Mol Dis 2007; 39: 63-69.
31. Ayi K, Min-Oo G, Serghides L, Crockett M, Kirby-Allen M, Quirt I et al. Pyruvate kinase deficiency and malaria. N Engl J Med 2008; 358: 1805-1810.
32. Ayi K, Liles WC, Gros P, Kain KC. Adenosine triphosphate depletion of erythrocytes simulates the phenotype associated with pyruvate kinase deficiency and confers protection against Plasmodium falciparum in vitro. J Infect Dis 2009; 200: 1289-1299.
33. Min-Oo G, Fortin A, Pitari G, Tam M, Stevenson MM, Gros P. Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. J Exp Med 2007; 204: 511-524.
34. Min-Oo G, Ayi K, Bongfen SE, Tam M, Radovanovic I, Gauthier S et al. Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium. Exp Parasitol 2010; 125: 315-324.
35. Min-Oo G, Fortin A, Poulin JF, Gros P. Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin. Antimicrob Agents Chemother 2010; 54: 3262-3270.
36. Min-Oo G, Willemetz A, Tam M, Canonne-Hergaux F, Stevenson MM, Gros P. Mapping of Char10, a novel malaria susceptibility locus on mouse chromosome 9. Genes Immun 2010; 11: 113-123.
37. Paigen K, Eppig JT. A mouse phenome project. Mamm Genome 2000; 11: 715-717.
38. Kang HM, Zaitlen NA, Wade CM, Kirby A, Heckerman D, Daly MJ et al. Efficient control of population structure in model organism association mapping. Genetics 2008; 178: 1709-1723.
39. Ohno T, Ishih A, Kohara Y, Yonekawa H, Terada M, Nishimura M. Chromosomal mapping of the host resistance locus to rodent malaria (Plasmodium yoelii) infection in mice. Immunogenetics 2001; 53: 736-740.
40. Wunderlich F, Marinovski P, Benten WP, Schmitt-Wrede HP, Mossmann H. Testosterone and other gonadal factor(s) restrict the efficacy of genes controlling resistance to Plasmodium chabaudi malaria. Parasite Immunol 1991; 13: 357-367.
41. Krucken J, Dkhil MA, Braun JV, Schroetel RM, El-Khadragy M, Carmeliet P et al. Testosterone suppresses protective responses of the liver to blood-stage malaria. Infect Immun 2005; 73: 436-443.
42. Wunderlich F, Mossmann H, Helwig M, Schillinger G. Resistance to Plasmodium chabaudi in B10 mice: influence of the H-2 complex and testosterone. Infect Immun 1988; 56: 2400-2406.
43. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 2007; 4: 651-657.
44. Cheverud JM. A simple correction for multiple comparisons in interval mapping genome scans. Heredity 2001; 87 (Pt 1): 52-58.